Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL1703872

CCCC[N+](CCCC)(CCCC)CCCC.[O]N1C(=O)c2ccccc2C1=O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
ASAH1 Q13510 1/20 0.46
ALDH1A1 P00352 1/20 0.46
ALDH2 P05091 1/20 0.46
ALDH3A1 P30838 1/20 0.46
CES1 P23141 2/20 0.45
CDC25A P30304 1/20 0.45
SLC22A1 O15245 1/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CHRM2 P08172 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL1703873 0.86 ASAH1 (0.48) NR1H2NR1H3ASAH1ALDH1A1ALDH2
Tetrabuthylammonium SCHEMBL8967565 0.78 SLC22A1 (0.44) NR1H2NR1H3ALDH1A1ALDH2ALDH3A1
Tetrabuthylammonium SCHEMBL8967570 0.78 GSK3B (0.56) ALDH1A1ALDH2ALDH3A1CES1CDC25A
SCHEMBL134793 0.77 POLB (0.56) ALDH1A1CES1CA12CA9MEN1
Tetrabuthylammonium SCHEMBL28914816 0.76 GSK3B (0.54) ALDH1A1ALDH2ALDH3A1CES1CDC25A
Tetrabuthylammonium SCHEMBL11246970 0.74 SLC22A1 (0.55) ALDH1A1SLC22A1MEN1KMT2A
Tetrabuthylammonium SCHEMBL3296432 0.73 SLC22A1 (0.60) ALDH1A1SLC22A1MEN1KMT2A
SCHEMBL29418113 0.73 ALDH1A1 (0.67) ALDH1A1ALDH2ALDH3A1CES1CDC25A
SCHEMBL45324 0.73 ALDH1A1 (0.67) ALDH1A1ALDH2ALDH3A1CES1CDC25A
Tetrabuthylammonium SCHEMBL15453961 0.72 SLC22A1 (0.52) ALDH1A1SLC22A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440557-B1 NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS BASF SE (DE) 2017-04-05 EP disclosed
US-9045480-B2 Sterically hindered amine light stabilizers BASF SE (DE) 2015-06-02 US disclosed
US-20120108709-A1 NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS BASF SE (DE) 2012-05-03 US disclosed
EP-2440557-A1 NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS BASF SE (DE) 2012-04-18 EP disclosed
WO-2010142576-A1 NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS BASF SE (DE) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108709-A1 NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS AAAS, CRY1, TAAR1 NR1H2 1925/4885NR1H3 1869/4885ASAH1 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.